Trial Outcomes & Findings for Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate? (NCT NCT02950753)

NCT ID: NCT02950753

Last Updated: 2019-04-12

Results Overview

Final mean lactate minus initial mean lactate

Recruitment status

COMPLETED

Study phase

EARLY_PHASE1

Target enrollment

30 participants

Primary outcome timeframe

5 minutes after IV bolus has ended.

Results posted on

2019-04-12

Participant Flow

Participant milestones

Participant milestones
Measure
Lactated Ringer
Intravenous bolus of Lactated Ringer solution (30ml/kg) via 18ga IV catheter at wide open. Lactated Ringer Solution: Fluid bolus of Lactated Ringer solution (30ml/kg).
Normal Saline
Intravenous bolus of Normal Saline (30ml/kg) via 18ga IV catheter at wide open. Normal Saline: Fluid bolus or Normal Saline (30ml/kg).
Overall Study
STARTED
15
15
Overall Study
COMPLETED
15
15
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lactated Ringer
n=15 Participants
Intravenous bolus of Lactated Ringer solution (30ml/kg) via 18ga IV catheter at wide open. Lactated Ringer Solution: Fluid bolus of Lactated Ringer solution (30ml/kg).
Normal Saline
n=15 Participants
Intravenous bolus of Normal Saline (30ml/kg) via 18ga IV catheter at wide open. Normal Saline: Fluid bolus or Normal Saline (30ml/kg).
Total
n=30 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=15 Participants
0 Participants
n=15 Participants
0 Participants
n=30 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
n=15 Participants
15 Participants
n=15 Participants
30 Participants
n=30 Participants
Age, Categorical
>=65 years
0 Participants
n=15 Participants
0 Participants
n=15 Participants
0 Participants
n=30 Participants
Sex: Female, Male
Female
3 Participants
n=15 Participants
8 Participants
n=15 Participants
11 Participants
n=30 Participants
Sex: Female, Male
Male
12 Participants
n=15 Participants
7 Participants
n=15 Participants
19 Participants
n=30 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
15 participants
n=15 Participants
15 participants
n=15 Participants
30 participants
n=30 Participants

PRIMARY outcome

Timeframe: 5 minutes after IV bolus has ended.

Final mean lactate minus initial mean lactate

Outcome measures

Outcome measures
Measure
Lactated Ringer
n=15 Participants
Intravenous bolus of Lactated Ringer solution (30ml/kg) via 18ga IV catheter at wide open. Lactated Ringer Solution: Fluid bolus of Lactated Ringer solution (30ml/kg).
Normal Saline
n=15 Participants
Intravenous bolus of Normal Saline (30ml/kg) via 18ga IV catheter at wide open. Normal Saline: Fluid bolus or Normal Saline (30ml/kg).
Change in Mean Lactate Level of the LR Group Compared to the NS Group.
0.93 mmol/L
Interval 0.42 to 1.44
0.37 mmol/L
Interval -0.26 to 1.0

SECONDARY outcome

Timeframe: 5 minutes after IV bolus has ended.

Baseline serum bicarbonate will be measured in both groups just prior to IV administration and again at 5 minutes after IV bolus has ended.

Outcome measures

Outcome measures
Measure
Lactated Ringer
n=15 Participants
Intravenous bolus of Lactated Ringer solution (30ml/kg) via 18ga IV catheter at wide open. Lactated Ringer Solution: Fluid bolus of Lactated Ringer solution (30ml/kg).
Normal Saline
n=15 Participants
Intravenous bolus of Normal Saline (30ml/kg) via 18ga IV catheter at wide open. Normal Saline: Fluid bolus or Normal Saline (30ml/kg).
Decrease in Bicarbonate Level of the LR Group Compared to the NS Group
-0.36 mEq/L
Standard Deviation 2.6
2.35 mEq/L
Standard Deviation 2.1

SECONDARY outcome

Timeframe: 5 minutes after IV bolus has ended.

Baseline serum chloride will be measured in both groups just prior to IV administration and again at 5 minutes after IV bolus has ended.

Outcome measures

Outcome measures
Measure
Lactated Ringer
n=15 Participants
Intravenous bolus of Lactated Ringer solution (30ml/kg) via 18ga IV catheter at wide open. Lactated Ringer Solution: Fluid bolus of Lactated Ringer solution (30ml/kg).
Normal Saline
n=15 Participants
Intravenous bolus of Normal Saline (30ml/kg) via 18ga IV catheter at wide open. Normal Saline: Fluid bolus or Normal Saline (30ml/kg).
Final Chloride Level Minus Initial Chloride Level of the LR Group Compared to the NS Group
-0.4 mEq/L
Standard Deviation 2.4
3.7 mEq/L
Standard Deviation 1.4

Adverse Events

Lactated Ringer

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Normal Saline

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Tony Zitek

UMCSouthernNevada

Phone: 702-383-7885

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place